I agree that this site is using cookies. You can find further informations here.
X
Sawalha, K
106  results:
Search for persons X
?
1

Utilization patterns of SGLT2 inhibitors and GLP-1 receptor..:

Sawalha, K ; Smith, A ; Chrisler, O.
The American Journal of the Medical Sciences.  367 (2024)  - p. S3-S4 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Prevalence of early repolarization ST-segment changes durin..:

Sawalha, K ; Shatla, I ; Mosinska, M.
The American Journal of the Medical Sciences.  365 (2023)  - p. S55 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Fragmentation of QRS complexes during SARS-CoV-2 infection:..:

Sawalha, K ; Shatla, I ; Mosinska, M.
The American Journal of the Medical Sciences.  365 (2023)  - p. S55-S56 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Prevalence and most commonly encountered QRS fragmentation ..:

Sawalha, K ; Shatla, I ; Mosinska, M.
The American Journal of the Medical Sciences.  365 (2023)  - p. S5 , 2023
Link: https://doi.org/10.1016/..
 
?
5

EP11.03-01 Real World Outcomes of Immunotherapy for Treatme..:

Abu Hejleh, T. ; AL Sawalha, K. ; Abdel Hafiz, S....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S619 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Dusty gas flow through porous media:

Hamdan, M.H. ; Sawalha, K.D.
Applied Mathematics and Computation.  75 (1996)  1 - p. 59-73 , 1996
Link: https://doi.org/10.1016/..
 
?
7

The impact of acute kidney injury stages on the outcomes of..:

Kallur, Akhil S. ; Armijo‐Alba, Julian ; Russell, Jacqueline L....
Artificial Organs.  48 (2024)  7 - p. 763-770 , 2024
Link: https://doi.org/10.1111/..
 
?
8

PO-06-075 SAFETY AND OUTCOMES OF CATHETER ABLATION PROCEDUR..:

Motta, Jishu K. ; Sawalha, Khalid ; Ezenna, Chidubem...
Heart Rhythm.  21 (2024)  5 - p. S697 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Outcomes of Patients with ALK+ Anaplastic Large Cell Lympho..:

Sorrell, Mckenzie ; Ip, Andrew ; Stuver, Robert...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S363-S364 , 2024
Link: https://doi.org/10.1016/..
 
?
10

OUTCOMES OF AUTOLOGOUS TRANSPLANT, ALLOGENEIC TRANSPLANT, A..:

Messmer, M. ; Stack, A. ; Deng, M....
Hematological Oncology.  41 (2023)  S2 - p. 156-158 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Impact of diagnosis to treatment interval in patients with ..:

Epperla, Narendranath ; Switchenko, Jeffrey ; Bachanova, Veronika...
Blood Advances.  7 (2023)  11 - p. 2287-2296 , 2023
Link: https://doi.org/10.1182/..
 
?
12

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with..:

Hanel, Walter ; Shindiapina, Polina ; Bond, David A....
Cancers.  15 (2023)  5 - p. 1437 , 2023
Link: https://doi.org/10.3390/..
 
?
13

Postibrutinib relapse outcomes for patients with marginal z..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
Blood Advances.  7 (2023)  1 - p. 88-91 , 2023
Link: https://doi.org/10.1182/..
 
?
14

Combination of the PD‐1 inhibitor Nivolumab and Immunomodul..:

Bond, D. A. ; Wei, L. ; Yildiz, V....
Hematological Oncology.  41 (2023)  S2 - p. 597-598 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Impact of detectable monoclonal protein at diagnosis on out..:

Epperla, Narendranath ; Zhao, Qiuhong ; Karmali, Reem...
Blood Advances.  7 (2023)  17 - p. 5038-5046 , 2023
Link: https://doi.org/10.1182/..
 
1-15